{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/05/3287482/0/en/Kymera-Therapeutics-Presents-New-Preclinical-IBD-Data-for-KT-579-a-First-in-Class-Oral-IRF5-Degrader-at-Digestive-Disease-Week.html", "message": "News view counter 702841 successfully enlarged"}